Works matching IS 11707690 AND DT 2011 AND VI 29 AND IP 10
Results: 7
Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 10, p. 895, doi. 10.2165/11539980-000000000-00000
- By:
- Publication type:
- Article
Critical Assessment of Belgian Reimbursement Dossiers of Orphan Drugs.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 10, p. 883, doi. 10.2165/11585980-000000000-00000
- By:
- Publication type:
- Article
Does the Market Share of Generic Medicines Influence the Price Level?: A European Analysis.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 10, p. 875, doi. 10.2165/11585970-000000000-00000
- By:
- Publication type:
- Article
Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer: A Systematic Review of the Literature.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 10, p. 863, doi. 10.2165/11589300-000000000-00000
- By:
- Publication type:
- Article
A Review of the Costs and Cost Effectiveness of Interventions in Chronic Kidney Disease: Implications for Policy.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 10, p. 839, doi. 10.2165/11588390-000000000-00000
- By:
- Publication type:
- Article
Cautions Regarding the Fitting and Interpretation of Survival Curves: Examples from NICE Single Technology Appraisals of Drugs for Cancer.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 10, p. 827, doi. 10.2165/11585940-000000000-00000
- By:
- Publication type:
- Article
Addressing the Challenge for Well Informed and Consistent Reimbursement Decisions: The Case for Reference Models.
- Published in:
- 2011
- By:
- Publication type:
- Editorial